<DOC>
<DOCNO>
EP-0004255
</DOCNO>
<TEXT>
<DATE>
19790919
</DATE>
<IPC-CLASSIFICATIONS>
C07D-265/00 A61P-37/00 C07D-221/00 A61P-37/08 C07D-221/08 A61K-31/435 <main>C07D-221/08</main> C07D-265/12 
</IPC-CLASSIFICATIONS>
<TITLE>
4-hydroxy-naphthopyridin-2(1h)-3-one carboxylic acids, their esters, process for their preparation, and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
sandoz agch<sep>sandoz ag<sep>sandoz aglichtstrasse 354002 baselch<sep>sandoz ag<sep>
</APPLICANT>
<INVENTOR>
hardtmann goetz eduard<sep>hardtmann, goetz eduard<sep>hardtmann, goetz eduard12 lynnfield drivemorristown n.j. 07960us<sep>hardtmann, goetz eduard<sep>hardtmann, goetz eduard12 lynnfield drivemorristown n.j. 07960us<sep>
</INVENTOR>
<ABSTRACT>
naphthopyridones of formula (i) and their mono- and di-salts with pharmaceutically acceptable cations are new: (ro is h, 1-6 c alkyl), 3-6 c alkenyl, alkynyl or cycloalkyl, 3-6 c cycloalkyl-(1-2 c) alkyl or the gp.  the unsatd.  position in alkenyl or alkynyl is not attached to the alpha-carbon; r" is h or 1-4 c alkyl; r and r' are h, f, cl, br or 1-4 c alkyl or alkoxy; n is 0 or 1; y and y' are h, f, cl, br, 1-3 c alkyl or alkoxy, or cf3).  (i) have similar activity to dina chromoglycate, esp.  they inhibit release of histamine so are useful in treating e. g.  allergic asthma.  the dose is 0. 3-100 mg/kg and (i) may be given orally.  -
</ABSTRACT>
</TEXT>
</DOC>
